<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Emeritus Corp.</title>
	<atom:link href="http://www.stockbloghub.com/tag/emeritus-corp/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(AZN) Good News for AstraZeneca on Crestor, its Cholesterol-Lowering Drug</title>
		<link>http://www.stockbloghub.com/2009/09/01/azn-good-news-for-astrazeneca-on-crestor-its-cholesterol-lowering-drug/14095</link>
		<comments>http://www.stockbloghub.com/2009/09/01/azn-good-news-for-astrazeneca-on-crestor-its-cholesterol-lowering-drug/14095#comments</comments>
		<pubDate>Tue, 01 Sep 2009 21:39:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[AstraZeneca plc]]></category>
		<category><![CDATA[AZN]]></category>
		<category><![CDATA[Emeritus Corp.]]></category>
		<category><![CDATA[ESC]]></category>
		<category><![CDATA[Merck & Company Inc.]]></category>
		<category><![CDATA[MRK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=14095</guid>
		<description><![CDATA[Yesterday, AstraZeneca Plc (AZN) announced that Crestor, its cholesterol-lowering drug (statin) reduced the risk of heart attacks, strokes, artery-clearing procedures and death in elderly patients. The results from the JUPITER study (Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin), showed that Crestor 20mg reduced major cardiovascular events. The administration of the drug to a sub-set of 5,695 patients aged 70 years or above reduced the risk of cardiovascular events by 39% compared to placebo. The study also revealed that Crestor reduced the risk of heart attack as well as stroke by 45% each in 17,802 patients (the total population of the study). The results were presented at the European Society of Cardiology (ESC) meeting in Barcelona, Spain. Results from the randomized, double-blind, placebo-controlled study ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/09/01/azn-good-news-for-astrazeneca-on-crestor-its-cholesterol-lowering-drug/14095/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SRZ) Alzheimer’s Care Key to Healthcare Facilities Sector</title>
		<link>http://www.stockbloghub.com/2009/05/13/srz-alzheimer%e2%80%99s-care-key-to-healthcare-facilities-sector/6993</link>
		<comments>http://www.stockbloghub.com/2009/05/13/srz-alzheimer%e2%80%99s-care-key-to-healthcare-facilities-sector/6993#comments</comments>
		<pubDate>Wed, 13 May 2009 23:21:16 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Long-Term Care Facilities]]></category>
		<category><![CDATA[Emeritus Corp.]]></category>
		<category><![CDATA[ESC]]></category>
		<category><![CDATA[Five Star Quality Care Inc.]]></category>
		<category><![CDATA[FVE]]></category>
		<category><![CDATA[SRZ]]></category>
		<category><![CDATA[Sunrise Senior Living Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=6993</guid>
		<description><![CDATA[by The Investment U Research Team We’ve been talking about Sunrise Assisted Living (NYSE: SRZ) recently, and the potential for some of its competitors to become major threats in this sector. There are only a couple of contenders likely to step up and do just that… Emeritus (NYSE: ESC) and Five Star Quality Care (NYSE: FVE) are the most likely candidates. These companies run assisted living and nursing home communities for the elderly. Based on the market capitalization, Five Star is the most undervalued prospect here followed by Sunrise and Emeritus. But all are profitable organizations making their principals quite happy. And like sunrise, the biggest issues these companies face is control of their debt loads. Now what you need to look at carefully is the number of Alzheimer’s care ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/05/13/srz-alzheimer%e2%80%99s-care-key-to-healthcare-facilities-sector/6993/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

